InspireMD Inc. (NSPR)
undefined
undefined%
At close: undefined
2.95
-0.67%
After-hours Dec 13, 2024, 04:00 PM EST

Company Description

InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific.

The company offers CGuard carotid embolic prevention system for use in carotid artery applications; and MGuard Prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions, as well as bypass surgery.

It is also developing PVGuard, a MicroNet mesh sleeve and self-expandable stent for use in peripheral vascular applications.

The company sells its products through local distributors.

InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.

InspireMD Inc.
InspireMD Inc. logo
Country IL
IPO Date Apr 12, 2011
Industry Medical - Devices
Sector Healthcare
Employees 65
CEO Marvin L. Slosman

Contact Details

Address:
4 Menorat Hamaor Street
Tel Aviv,
IL
Website https://www.inspiremd.com

Stock Details

Ticker Symbol NSPR
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001433607
CUSIP Number 45779A853
ISIN Number US45779A8466
Employer ID 26-2123838
SIC Code 3841

Key Executives

Name Position
Marvin L. Slosman President, Chief Executive Officer & Director
Andrea Tommasoli Chief Operating Officer
Craig Shore Chief Financial Officer, Chief Administrative Officer, Secretary & Treasurer
Amir Kohen Senior Vice President of Finance & HR
Dr. Patrick A. Verta DVM, M.D., MS Stat Executive Vice President of Clinical & Medical Affairs
Dr. Sol J. Barer Ph.D. Special Advisor to the Board
Pete J. Ligotti Executive Vice President & GM of North America
Shane Thomas Gleason Chief Commercial Officer

Latest SEC Filings

Date Type Title
Dec 12, 2024 8-K Current Report
Dec 09, 2024 8-K Current Report
Dec 04, 2024 SC 13G Statement of acquisition of beneficial ownership b...
Nov 27, 2024 3 Filing
Nov 25, 2024 8-K Current Report
Nov 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Nov 14, 2024 SCHEDULE 13G/A [Amend] Filing
Nov 12, 2024 8-K Current Report
Nov 12, 2024 10-Q Quarterly Report
Oct 28, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...